Steinman MA et al. |
Changing use of antibiotics in community-based outpatient practice, 1991-1999. |
2003 |
Ann. Intern. Med. |
pmid:12667022
|
Goldberger M and Masur H |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems. |
1994 |
Ann. Intern. Med. |
pmid:7978725
|
Vaira D et al. |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. |
2007 |
Ann. Intern. Med. |
pmid:17438314
|
Singh N and Yu VL |
Clarithromycin therapy for Mycobacterium avium complex bacteremia. |
1995 |
Ann. Intern. Med. |
pmid:7632282
|
Liviu L et al. |
Pancreatitis induced by clarithromycin. |
1996 |
Ann. Intern. Med. |
pmid:8849171
|
|
Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics. |
2002 |
Ann. Intern. Med. |
pmid:11797613
|
Trivedi S et al. |
Clarithromycin and digoxin toxicity. |
1998 |
Ann. Intern. Med. |
pmid:9518419
|
Yang YJ et al. |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. |
2017 |
Ann. Med. |
pmid:28266875
|
Trotti LM et al. |
Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. |
2015 |
Ann. Neurol. |
pmid:26094838
|
Ferreri AJ et al. |
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. |
2015 |
Ann. Oncol. |
pmid:25935794
|
Di Raimondo F et al. |
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? |
2007 |
Ann. Oncol. |
pmid:17065587
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Heffernan CB et al. |
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. |
2018 |
Ann. Otol. Rhinol. Laryngol. |
pmid:30032669
|
Clifford K et al. |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10214783
|
Mullin D et al. |
Mycobacterium chelonae infections involving the head and neck. |
2009 |
Ann. Otol. Rhinol. Laryngol. |
pmid:19894399
|
Callaghan R and Allen M |
Mycobacterium malmoense infection of the knee. |
2003 |
Ann. Rheum. Dis. |
pmid:14583565
|
Hiramatsu M et al. |
Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. |
2012 |
Ann. Thorac. Surg. |
pmid:22119119
|
Fan X et al. |
Lung perfusion with clarithromycin ameliorates lung function after cardiopulmonary bypass. |
2006 |
Ann. Thorac. Surg. |
pmid:16488691
|
Nelson KG et al. |
Results of operation in Mycobacterium avium-intracellulare lung disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9725364
|
Kadir IS et al. |
Recurrent acute rheumatic fever: a forgotten diagnosis? |
2004 |
Ann. Thorac. Surg. |
pmid:15276555
|
Bossert T et al. |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections. |
2005 |
Ann. Thorac. Surg. |
pmid:16039241
|
Watanabe M et al. |
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. |
2006 |
Ann. Thorac. Surg. |
pmid:16731124
|
Gintovt EA |
[Use of clarithromycin in the treatment of atopic dermatitis complicated by staphylococcal infection]. |
2004 |
Antibiot. Khimioter. |
pmid:15164520
|
Vasil'ev IuV and Zvenigorodskaia LA |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer]. |
2002 |
Antibiot. Khimioter. |
pmid:12365323
|
Iakovlev EA et al. |
[Present stage of chemotherapy and chemoprophylaxis of rickettsiosis and Q fever]. |
2011 |
Antibiot. Khimioter. |
pmid:22856156
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Evdokimova AG et al. |
[New approaches to therapy of Helicobacterpylori infection (by the materials of the Maastricht Consensus-IV, Florence, 2010)]. |
2013 |
Antibiot. Khimioter. |
pmid:24640139
|
Iakovlev VP et al. |
[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections]. |
2000 |
Antibiot. Khimioter. |
pmid:11210297
|
Shcherbakov PL |
[Clarithromycin in eradication therapy of helicobacter infections in children]. |
2001 |
Antibiot. Khimioter. |
pmid:11871315
|
Sazykin IuO et al. |
[Clarithromycin and tumor chemotherapy]. |
2000 |
Antibiot. Khimioter. |
pmid:11210301
|
Iutanova NS |
[Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia]. |
2004 |
Antibiot. Khimioter. |
pmid:15344392
|
Budanov SV and Vasil'ev AN |
[Clarithromycin: specific features of antimicrobial spectrum and clinical use]. |
2004 |
Antibiot. Khimioter. |
pmid:15285409
|
Guchev IA et al. |
[Evaluation of clarithromycin efficacy in the treatment of community-acquired pneumonia on the basis of the Binax NOW test results (a prospective open trial)]. |
2002 |
Antibiot. Khimioter. |
pmid:12619516
|
Aoki D et al. |
Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production. |
|
Anticancer Res. |
pmid:15816530
|
Ohara T et al. |
Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736403
|
Hardy DJ et al. |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2143642
|
GarcÃa-Arata MI et al. |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9925537
|
Phillips RO et al. |
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24323473
|
Matic V et al. |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504828
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Spyridaki A et al. |
Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22564837
|
Ellis LC et al. |
Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593025
|
Truffot-Pernot C et al. |
Clarithromycin is inactive against Mycobacterium tuberculosis. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593032
|
Ramón-GarcÃa S et al. |
Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21576426
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Secka O et al. |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23263004
|
Hultén K et al. |
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371366
|
Liu KY et al. |
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24687504
|
Renvoisé A et al. |
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26324275
|
Best LM et al. |
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506021
|